OTHER SOLID TUMORS
Clinical trials for OTHER SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new OTHER SOLID TUMORS trials appear
Sign up with your email to follow new studies for OTHER SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in humans testing a new drug called DXC008 for people with advanced prostate cancer and other solid tumors like Ewing sarcoma who have run out of standard treatment options. The main goals are to find the safest dose, check for side effects, and see how th…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 21:26 UTC
-
Experimental drug offers hope for advanced cancers with no other options
Disease control Recruiting nowThis early-stage trial is testing a new drug called BL-M05D1 in people with advanced cancers that have spread and stopped responding to standard treatments. The study will enroll 120 patients with specific cancers like stomach, pancreatic, and esophageal cancer to determine the s…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First-in-Human trial launches for personalized Cancer-Killing cell therapy
Disease control Recruiting nowThis is a first-in-human study testing a new personalized cell therapy called NT-175. It is for adults with advanced solid cancers (like lung, colorectal, or breast cancer) that have spread and have a specific genetic mutation (TP53 R175H). The main goals are to find a safe dose …
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First human test for new cancer drug targets tough tumors
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new drug called BL-M07D1. It is for adults with advanced digestive tract cancers (like stomach or colon cancer) or other solid tumors that have spread and have stopped responding to standard treatments…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New targeted drug trial seeks to control Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called IDE196, both alone and combined with other drugs, for people with advanced cancers that have specific genetic changes (GNAQ/11 mutations or PRKC fusions). The main goals are to find safe doses and see if the treatments can shrink tumors. It…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC